Skip to main content

Profile: Jeffrey Sherer

Jeffrey Sherer
Jeffrey T. Sherer, Pharm.D., MPH, BCPS, CGP
Clinical Associate Professor
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
Health and Biomedical Sciences Building 2
4849 Calhoun Road, Room 4026
Houston, TX 77204-5039
832-842-8307
832-842-8383 (Fax)
JTSherer@uh.edu

Education

Bachelor of Science in Pharmacy (cum laude), The Ohio State University, Columbus, OH, 1994

Doctor of Pharmacy, Medical University of South Carolina, Charleston, SC, 1996

Residency in Pharmacy Practice with an Emphasis in Primary Care, Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC, 1997

Master of Public Health, University of Texas School of Public Health, Houston, TX, 2006. Thesis: Outcomes of Patients Receiving Zoledronic Acid or Pamidronate for Prevention of Skeletal-Related Events in Prostate Cancer.

Research Interests

Geriatrics, clinical epidemiology and evidence-based medicine, general medicine, primary care.

Awards & Honors

  • "October 2011 Professor of the Month," Doctor of Pharmacy Class of 2013
  • Educator Excellence Award, Texas Society of Health-System Pharmacists Student Section, 2011
  • Recipient, Rho Chi Teaching Excellence Award, Beta Omicron Chapter, UH College of Pharmacy, 2011
  • Honorable Mention, Rho Chi Teaching Excellence Award, Beta Omicron Chapter, UH College of Pharmacy, 2010, 2009 and 2006
  • March 2010 Professor of the Month, UHCOP Doctor of Pharmacy Class of 2012
  • Co-MVP (Most Valuable Professor) Award, UHCOP Doctor of Pharmacy Class of 2009
  • Nominee, Faculty Teaching Excellence Award, UH College of Pharmacy, 2009 and 2006
  • Best Lecturer Award, UHCOP Doctor of Pharmacy Class of 2008
  • Faculty Preceptor of the Year, UH College of Pharmacy, 2007
  • Favorite Professor Award, UHCOP Doctor of Pharmacy Class of 2006
  • Nominee, John P. McGovern Outstanding Teacher Award, University of Texas School of Nursing, 2006-07

Courses

  • Introduction to Community Health
  • Cellular Life Sciences II
  • Pharmacy Practice IV
  • Pharmacodynamics II
  • Advanced Therapeutics I
  • Advanced Therapeutics II
  • Introduction to Pharmacy
  • Pharmacy and Geriatrics
  • Preceptor for Institutional Medicine clinical clerkship

Selected Peer-reviewed Publications

Patel A, Chan W, Aparasu RR, Ochoa-Perez M, Sherer JT, Medhekar R, Chen H. Effect of Psychopharmacotherapy on Body Mass Index Among Children and Adolescents with Bipolar Disorders. J Child Adolesc Psychopharmacol. 2017 May;27(4):349-358. doi: 10.1089/cap.2016.0133. PMID: 28422528

Patel A, Medhekar R, Ochoa-Perez M, Aparasu RR, Chan W, Sherer JT, Alonzo J, Chen H. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD. Psychiatr Serv. 2017 Jul 1;68(7):681-688. doi: 10.1176/appi.ps.201600130. PMID: 28196459

Blee J, Roux RK, Gautreaux S, Sherer JT, Garey KW. Dispensing inhalers to patients with chronic obstructive pulmonary disease on hospital discharge: Effects on prescription filling and readmission. Am J Health Syst Pharm. 2015 Jul 15;72(14):1204-8. doi: 10.2146/ajhp140621. PMID: 26150570

Bhowmik D, Aparasu RR, Rajan SS, Sherer JT, Ochoa-Perez M, Chen H. Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression. J Child Adolesc Psychopharmacol. 2014 Dec;24(10):551-61. doi: 10.1089/cap.2014.0028. PMID: 25470655

Sherer JT. Principles of Evidence-Based Medicine. In: Aparasu RR, Bentley JP, eds. Principles of Research Design and Drug Literature Evaluation. Burlington, MA: Jones & Bartlett Learning;2014:243-256.

Bhowmik D, Aparasu RR, Rajan SS, Sherer JT, Ochoa-Perez M, Chen H. The utilization of psychopharmacological treatment and medication adherence among Medicaid enrolled children and adolescents with bipolar depression. J Affect Disord. 2013 Sep 5;150(2):424-9. doi: 10.1016/j.jad.2013.04.034.

Chen H, Patel A, Sherer J, Aparasu R. The Definition and Prevalence of Pediatric Psychotropic Polypharmacy. Psychiatric Services. 2011;62:1450-5.

Goyal RK, Williams DH, Sansgiry SS, Patel HK, Sherer JT, Essien EJ. Awareness and Perceived Usefulness of the Website Designed to Facilitate Access and Informed Health Insurance Decisions. Texas Public Health Journal. 2010;62(3):8-11.

Chatterjee S, Mehta S, Sherer JT, Aparasu RR. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey. Drugs Aging. 2010 Dec 1;27(12):987-97.

Nagar S, Sherer JT, Chen H, Aparasu RR. Extent of functional impairment in children and adolescents with depression. Curr Med Res Opin. 2010 Sep;26(9):2057-64.

Dasgupta A, Sansgiry SS, Sherer JT, Wallace D, Sikri S. Pharmacists’ Utilization and Interest in Usage of Personal Digital Assistants in Their Professional Responsibilities. Health Information and Libraries Journal. 2010;27:37-45.

Kamble P, Chen H, Sherer J, Aparasu R. Off-label Use of Second-generation Antipsychotic Agents among Elderly Nursing Home Residents in the United States. Psychiatric Services. 2010;61:130-6

Dasgupta A, Sansgiry SS, Sherer JT, Wallace D, Sikri S. Application of the Extended Technology Acceptance Model in Predicting Pharmacists’ Intention to Use Personal Digital Assistants. Journal of the American Pharmacists Association. 2009;49:792-6.

Kamble P, Chen H, Sherer JT, Aparasu RR. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs and Aging. 2009;26(6):483-92. 

Kamble P, Chen H, Sherer J, Aparasu RR. Antipsychotic Use Among Elderly Nursing Home Residents in the United States. American Journal of Geriatric Pharmacotherapy. 2008;6:187-97.

White J, Sherer J. Medication Use in Today’s Elderly Population. America’s Pharmacist. 2008;130(2):39-51. ACPE program number 207-000-08-002-H01-P

Sherer JT. Nonalzheimer’s Dementias. U.S. Pharmacist. 2007;32(12):26-34.

Sherer JT, Adamus AT. Outcomes of Patients Receiving Zoledronic Acid or Pamidronate for Prevention of Skeletal-Related Events in Prostate Cancer. Pharmacotherapy. 2007;27:207-17.

Kodityal S, Nguyen P, Kodityal A, Sherer J, Hursting MJ, Rice L. Argatroban for Suspected Heparin-Induced Thrombocytopenia: Contemporary Experience at a Large Teaching Hospital. Journal of Intensive Care Medicine. 2006;21:86-92.

Sherer JT. Pharmaceuticals in the Environment. American Journal of Health-System Pharmacy. 2006;63:174-8.

Other Publications & Formulary Monographs

Sherer JT. Adrenocorticoids: Scenario and Clinical Significance. In: Lemke TL, Williams DA, eds. Foye’s Principles of Medicinal Chemistry. 7th ed. Baltimore: Lipincott Williams & Wilkins;2013:908-0

Dasgupta A, Sansgiry S, Frost C, Tipton J, Sherer J. Medication Administration Process Conducted by Nurses in Intensive and Acute Care Units of a Hospital: a Time and Motion Study.Value in Health. 2009;12:A96 (abstract)

Sherer JT. Supplementary Materials for Chapter 12, Pharmacotherapy of the Geriatric Patient. In: Adams MP, Kock RW. Pharmacology: Connections to Nursing Practice. 1st ed. Upper Saddle River, NJ: Pearson;2010.

Sherer JT. Ask the Pharmacist: Seizure Medication. In: Howard A, ed. Branching Out. 2008;22(4):15.The Sturge-Weber Foundation, Mt. Freedom, NJ

Sherer JT. Adrenocorticoids: Clinical Significance. In: Lemke TL, Williams DA, eds. Foye’s Principles of Medicinal Chemistry. 6th ed. Baltimore: Lipincott Williams & Wilkins;2008:878.

Sherer JT. Cardiac Agents: Cardiac Glycosides, Antianginal, and Antiarrhythmic Drugs: Clinical Significance. In: Lemke TL, Williams DA, eds. Foye’s Principles of Medicinal Chemistry. 6th ed. Baltimore: Lipincott Williams & Wilkins;2008:699.

Birtcher KK, Sherer JT, Wehmanen O, Brehm B, Greisinger, Rice G, Mirzai-Tehrane M, Rashid H, Mortazavi A. Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Care for Very-high Risk Patients with Diabetes and Coronary Heart Disease. Clin Lipidology. 2007;1:155-6. (abstract)

Sherer JT. Ask the Pharmacist. In: Howard A, ed. Branching Out. 2006;20(3):13. The Sturge-Weber Foundation, Mt. Freedom, NJ

Presentations & Abstracts

Bhowmik D, Chen H, Aparasu R, Rajan S, Sherer J, Perez MO. Psychotropic Medication Use Pattern Among Medicaid Enrolled Children and Adolescents with Bipolar Depression University of Houston College of Pharmacy, Houston, TX. Presented at the 7th Asian Conference on Pharmacoepidemiology, Bengaluru, India, October 2012.

Bhowmik D, Chen H, Aparasu RR, Rajan S, Sherer JT, Perez MO. Pharmacotherapy and Associated Outcomes in Pediatric Bipolar Depression. University of Houston College of Pharmacy, Houston, TX. Presented at the International Society of Pharmacoeconomics and Outcomes Research 17th Annual International Meeting, Washington, DC, June 2012.

Mhatre S, Abughosh S, Sherer J, Sansgiry SS. Medication Belief and Relationship with Physicians. University of Houston College of Pharmacy, Houston, TX Presented at the Kelsey Research Foundation’s 12th Annual Health Services and Outcomes Research Conference, Houston, TX, November 2011.

Palli SR, Aparasu RR, Chen H, Sherer JT. Persistence of Stimulant Treatment in Children and Adolescents with Attention-Deficit Hyperactivity Disorder. University of Houston College of Pharmacy, Houston, TX Presented at the International Society of Pharmacoeconomics and Outcomes Research 16th Annual International Meeting, Baltimore, MD, May 2011.

Palli SR, Aparasu RR, Chen H, Sherer JT. Psychotropic Polypharmacy in Children and Adolescents with Attention-Deficit Hyperactivity Disorder. University of Houston College of Pharmacy, Houston, TX Presented at the International Society of Pharmacoeconomics and Outcomes Research 16th Annual International Meeting, Baltimore, MD, May 2011.

Patel AR, Chen H, Aparasu RR, Sherer JT. Definition and Prevalance of Psychotropic Polypharmacy in Medicaid Children and Adolescents. University of Houston College of Pharmacy, Houston, TX. Presented at the International Society of Pharmacoeconomics and Outcomes.Presented at the International Society of Pharmacoeconomics and Outcomes Research 16th Annual International Meeting, Baltimore, MD, May 2011

Nagar S, Aparasu RR, Chen H, Sherer J. Health Care Expenditures in the Pediatric Population with Depression in the United States. Presented at the International Society of Pharmacoeconomics and Outcomes Research 15th Annual International Meeting, Atlanta, GA, May 2010

Nagar S, Aparasu RR, Chen H, Sherer J. Functional Impairment in Children and Adolescents with Depression. Presented at the International Society of Pharmacoeconomics and Outcomes Research 15th Annual International Meeting, Atlanta, GA, May 2010

Mehta H, Patel J, Parikh R, Aparasu RR, Sherer J. Ten-Year Trends in Prescription of Chronic Obstructive Pulmonary Disease Medication among Adults from 1996 to 2005. Presented at the International Society of Pharmacoeconomics and Outcomes Research 15th Annual International Meeting, Atlanta, GA, May 2010

Chatterjee S, Palli SR, Mehta S, Aprasu RR, Sherer JT.  Prevalence and Predictors of Anticholinergic Medication Use in Elderly Nursing Home Residents with Dementia. Presented at the International Society of Pharmacoeconomics and Outcomes Research 15th Annual International Meeting, Atlanta, GA, May 2010

Quadri S, Sherer JT, Birtcher KK, Rambin M, Jackson N, Salinas C, Patel T, Bernardo E. The Role of Calcium-Magnesium Infusions in the Delay of Onset of Oxaliplatin-Associated Neuropathy. Presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2008

Gee JS, Sherer JT, Hayes JD, Greisinger A, Jackson N, Martinez DM, Salinas CC, Lee TR, Simpson L, Birtcher KK. Primary Prevention Lipid Clinic with a Pharmacist on the Healthcare Team Attains LDL-C Goal More Often and Provides Additional Lipid Parameter Lowering After Usual Care. Presented at the Kelsey Research Foundation’s 9th Annual Health Services and Outcomes Research Conference, Houston, TX, December 2008 and the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2008

Dasgupta A, Sansgiry SS, Tipton JA, Frost CP, Sherer JT. Assessment of Workflow Parameters Associated with Barcode-Based Approach to Medication Administration. Presented at the Kelsey Research Foundation’s 9th Annual Health Services and Outcomes Research Conference, Houston, TX, December 2008 and the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2008

Goel K, Sherer JT, Furman LM, Greisinger A, Nayak A, Mirzai-Tehane M, Rashid H, Mortazavi A, Birtcher KK. Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Care for Very High-Risk Patients with Coronary Heart Disease and Risk Factors for the Metabolic Syndrome. Presented at the Kelsey Research Foundation’s 9th Annual Health Services and Outcomes Research Conference, Houston, TX, December 2008

Dasgupta A, Sansgiry SS, Sherer JT, Wallace D. Assessing the Difference in Behavioral Adoption and Utilization Patterns of Personal Digital Assistants Between Hospital and Community Pharmacists. Presented at American Pharmacists Association Annual Meeting and Exposition, San Diego, CA, March 2008

Birtcher KK, Sherer JT, Wehmanen O, Brehm B, Greisinger, Rice G, Mirzai-Tehrane M, Rashid H, Mortazavi A. Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Care for Very-high Risk Patients with Diabetes and Coronary Heart Disease. J Clin Lipidology. 2007;1:155-6. (abstract)

Putney D, Strapp E, Sherer J, Bernard D. Safety and Efficacy of Managing Heparin Protocols with Anti-Xa Levels. Presented at the Weill Cornell Medical College, New York-Presbyterian Hospital, and The Methodist Hospital Quality 2010: Evolving Frontiers in Quality and Patient Safety Symposium, Houston, TX, March 2007  *Honored as symposium’s best poster*

Birtcher KK, Sherer JT, Wehmanen O, Brehm B, Greisinger, Rice G, Mirzai-Tehrane M, Rashid H, Mortazavi A.  Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Care for Very-High Risk Patients with Diabetes and Coronary Heart Disease. Presented at the Kelsey Research Foundation’s 7th Annual Health Services and Outcomes Research Conference, Houston, TX, November 2006 and at the National Lipid Association Annual Scientific Sessions, Scottsdale, AZ, June 2007

Professional Service & Appointments

Professional Service

  • 2008 Annual Meeting Focus Session Planning Committee, 2007-2008.
    • Geriatrics Practice and Research Network
    • American College of Clinical Pharmacy, Kansas City, MO
  • Education Council, 2004-2005.
    • Gulf Coast Society of Health-System Pharmacists, Houston, TX
  • Alcalde XVIII Planning Committee, 2003-2004.
    • Alcalde Southwest Leadership Conference for Pharmacy Residents, Fellows, and Preceptors
    • Chairman
  • Patient and Family Education Subcommittee, 2003.
    • Palliative Care Steering Committee
    • The Methodist Hospital, Houston, TX
  • Patient Care Delivery Model Goal Group, 2003.
    • The Methodist Hospital, Houston, TX
  • Communications Committee, 2002-2006
    • Education & Training Practice and Research Network
    • American College of Clinical Pharmacy, Kansas City, MO
  • Professional Poster Reviewer, 46th Annual Midyear Clinical Meeting & Exhibition, 2011-12
    • American Society of Health-System Pharmacists, Bethesda, MD
  • Adult Medicine Practice and Research Network Poster Session Walk Rounds, 2010.
    • American College of Clinical Pharmacy Annual Meeting, Austin, TX

Other Services

  • Adjunct Associate Professor, 2014-present.
    • Baylor College of Medicine, Houston, TX
  • Advisor, American College of Clinical Pharmacy Student Chapter, 2013-present.
    • University of Houston College of Pharmacy, Houston, TX
  • Reviewer, Lilly Seed Grant Program, 2013.
    • Purdue University College of Pharmacy
  • Co-Director of Drug Information, 2012-2013.
    • University of Houston College of Pharmacy, Houston, TX
  • Student Mentor, TSHP Mentor Program, 2012-present.
    • Texas Society of Health-Systems Pharmacy
  • University of Houston College of Pharmacy Student Liaison, 2010-present.
    • American College of Clinical Pharmacy, Lenexa, KS
  • Co-Advisor, Rho Chi Society Beta Omicron Chapter, 2007-present.
    • University of Houston College of Pharmacy, Houston, TX

Editorial Appointments

  • Neurology Reviewer, Pharmacotherapy Flash Cards Project, 2013-2014.
    • American College of Clinical Pharmacy, Lenexa, KS
  • Professional Reviewer, Pharmacotherapy Self-Assessment Program, 8th ed, 2013-present.
    • American College of Clinical Pharmacy, Lenexa, KS
    • Chapters reviewed to date: Myelodysplastic Syndromes; Patients on Dialysis; Acute Renal Failure
  • Professional Reviewer, Ambulatory Care Self-Assessment Program, 1st ed., 2012-present.
    • American College of Clinical Pharmacy, Lenexa, KS
    • Chapters reviewed to date: Viral Hepatitis, Community-Acquired Pneumonia, Schizophrenia, Medication Management Services for Patients with Psychiatric and Neurologic Disorders, Autism Spectrum Disorder
  • Associate Editor, Tarascon Pharmacopoeia, 2010-present.
    • Jones & Bartlett Learning, Sudbury, MA
  • Peer Reviewer, BMC Geriatrics, 2010.
  • Peer Reviewer, Annals of Pharmacotherapy, 2010.
    • Also 1995
  • Peer Reviewer, American Journal of Pharmacy Education, 2008-present.
  • Peer Reviewer, American Journal of Managed Care, 2008-present.
    • Also 2001
  • Editorial Board Member, TSHP Journal, 2006-12.
    • Texas Society of Health-System Pharmacists, Round Rock, TX
  • Peer reviewer, American Journal of Health-System Pharmacy, 2005-present.
  • Peer Reviewer, Pharmacotherapy, 2000-present.

Memberships

  • American Association of Colleges of Pharmacy
    • Pharmacy Practice Section
    • Curriculum Special Interest Group
    • Geriatric Pharmacy Special Interest Group
  • American College of Clinical Pharmacy
    • Adult Medicine Practice and Research Network
    • Ambulatory Care Practice and Research Network
    • Education and Training Practice and Research Network
    • Geriatrics Practice and Research Network
  • American Heart Association
    • Scientific Council on Clinical Cardiology
  • American Society of Health-System Pharmacists
    • Section of Clinical Specialists and Scientists
    • Section of Inpatient Care Practitioners
  • Gulf Coast Society of Health-System Pharmacists
    • Rho Chi Society
    • Texas Society of Health-System Pharmacists
  • Phi Lambda Sigma
  • Rho Chi Society
  • Texas Society of Health-System Pharmacists